-+ 0.00%
-+ 0.00%
-+ 0.00%

LANTERN PHARMA SHARES UP 11.5% PREMARKET AFTER RECEIVING FDA CLEARANCE TO START CHILD BRAIN CANCER TREATMENT STUDY

Reuters·03/27/2026 12:19:56

Please log in to view news